Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:APEN

Apollo Endosurgery (APEN) Stock Price, News & Analysis

Apollo Endosurgery logo

About Apollo Endosurgery Stock (NASDAQ:APEN)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
$9.87
$10.00
52-Week Range
N/A
Volume
1.66 million shs
Average Volume
1.43 million shs
Market Capitalization
$579.72 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive APEN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Apollo Endosurgery and its competitors with MarketBeat's FREE daily newsletter.

APEN Stock News Headlines

Apollo Endosurgery Stock Price History
A new rule goes live in July — and the banks are quietly cashing in
A little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Street and the Big Banks… It gives them the green light to treat a certain tangible asset as equivalent to cold, hard cash. Not stocks. Not real estate. And definitely not the U.S. dollar. We're talking about something they don't want you to notice — because the fewer people who act on this, the better it is for them.
Apollo Pipes Ltd 531761
See More Headlines

APEN Stock Analysis - Frequently Asked Questions

Apollo Endosurgery, Inc. (NASDAQ:APEN) announced its earnings results on Sunday, October, 31st. The biotechnology company reported ($0.23) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.28) by $0.05. The biotechnology company earned $16.35 million during the quarter, compared to analyst estimates of $16.20 million. Apollo Endosurgery had a negative trailing twelve-month return on equity of 89.48% and a negative net margin of 51.84%.
Read the conference call transcript
.

Based on aggregate information from My MarketBeat watchlists, some other companies that Apollo Endosurgery investors own include Pfizer (PFE), Novavax (NVAX), NVIDIA (NVDA), Ocugen (OCGN), Canopy Growth (CGC), Inovio Pharmaceuticals (INO) and Meta Platforms (META).

Company Calendar

Last Earnings
10/31/2021
Today
7/10/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
N/A
Current Symbol
NASDAQ:APEN
CIK
1251769
Employees
202
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$39.84 million
Pretax Margin
-51.08%

Debt

Sales & Book Value

Annual Sales
$76.86 million
Price / Cash Flow
N/A
Book Value
$0.69 per share
Price / Book
N/A

Miscellaneous

Free Float
47,943,000
Market Cap
$579.72 million
Optionable
Not Optionable
Beta
2.31

Social Links

Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

This page (NASDAQ:APEN) was last updated on 7/10/2025 by MarketBeat.com Staff
From Our Partners